Suppr超能文献

离子导入混合胶束载体系统后药物脂溶性对药物从人巩膜释放的影响。

Influence of drug lipophilicity on drug release from sclera after iontophoretic delivery of mixed micellar carrier system to human sclera.

机构信息

Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio 45267, USA.

出版信息

J Pharm Sci. 2013 Feb;102(2):480-8. doi: 10.1002/jps.23370. Epub 2012 Nov 13.

Abstract

Mixed micelles prepared using sodium taurocholate (TA) and egg lecithin (LE) were previously found to be an effective carrier for sustained release of a poorly water-soluble drug in transscleral iontophoretic delivery. The objectives of the present study were to investigate the effects of drug lipophilicity upon micellar carrier solubilization potential and drug release profiles from the sclera after iontophoretic delivery of model lipophilic drugs dexamethasone (DEX), triamcinolone acetonide (TRIAM), and β-estradiol (E2β) with a mixed micellar carrier system of TA-LE (1:1 mole ratio). In this study, the micellar carrier system was characterized for drug solubilization. The micelles encapsulating these drugs were evaluated for transscleral passive and 2-mA iontophoretic delivery (both cathodal and anodal) and drug release from excised human sclera in vitro. The results show that drug solubility enhancement of the micellar carrier system increased with increasing drug lipophilicity. The more lipophilic drugs E2β and TRIAM displayed slower drug release from the sclera compared with the less lipophilic drug DEX after iontophoretic drug delivery with the mixed micelles. These results suggest that the combination of transscleral iontophoresis and micellar carriers is more effective in sustaining transscleral delivery of the more lipophilic drugs studied in this investigation.

摘要

先前的研究发现,使用牛磺胆酸钠(TA)和卵磷酯(LE)制备的混合胶束是一种有效的载体,可用于在经巩膜离子导入递药时持续释放亲脂性差的药物。本研究的目的是考察药物脂溶性对胶束载体增溶潜力的影响,以及在用 TA-LE(1:1 摩尔比)混合胶束载体系统经巩膜离子导入递药后,模型亲脂性药物地塞米松(DEX)、曲安奈德(TRIAM)和雌二醇(E2β)从巩膜中释放的药物释放特征。在本研究中,对胶束载体系统进行了药物增溶能力的特征描述。对包封这些药物的胶束进行了评估,以考察其经巩膜被动和 2-mA 离子导入(阴极和阳极)递药以及在离体人巩膜中的药物释放能力。结果表明,胶束载体系统的药物增溶能力随药物脂溶性的增加而提高。与脂溶性较低的药物 DEX 相比,经巩膜离子导入药物递送后,脂溶性更高的药物 E2β 和 TRIAM 从巩膜中的药物释放速度更慢。这些结果表明,联合使用经巩膜离子导入和胶束载体系统更有利于持续递药,这对本研究中考察的更亲脂性药物具有重要意义。

相似文献

6
Transscleral passive and iontophoretic transport: theory and analysis.经巩膜被动和离子导入传输:理论与分析。
Expert Opin Drug Deliv. 2018 Mar;15(3):283-299. doi: 10.1080/17425247.2018.1406918. Epub 2017 Dec 5.

本文引用的文献

3
Dexamethasone for ocular inflammation.地塞米松治疗眼部炎症。
Expert Opin Pharmacother. 2011 May;12(7):1127-31. doi: 10.1517/14656566.2011.571209. Epub 2011 Apr 2.
4
Complications of intravitreal injections.玻璃体腔内注射的并发症。
Curr Opin Ophthalmol. 2010 May;21(3):178-83. doi: 10.1097/ICU.0b013e328338679a.
8
Iontophoresis: a non-invasive ocular drug delivery.离子电渗疗法:一种非侵入性眼部给药方式。
J Control Release. 2006 Feb 21;110(3):479-89. doi: 10.1016/j.jconrel.2005.09.049. Epub 2005 Dec 15.
9
Periocular routes for retinal drug delivery.视网膜药物递送的眼周途径。
Expert Opin Drug Deliv. 2004 Nov;1(1):99-114. doi: 10.1517/17425247.1.1.99.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验